[1]陈明丽.栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的效果[J].医学信息,2021,34(24):154-156.[doi:10.3969/j.issn.1006-1959.2021.24.040]
　CHEN Ming-li.Effect of Modified Zhizi Dahuang Decoction Combined with Bifidobacterium Triple Viable Enteric-coated Capsules and Blue Light Irradiation on Neonatal Pathological Jaundice[J].Medical Information,2021,34(24):154-156.[doi:10.3969/j.issn.1006-1959.2021.24.040]
点击复制

栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年24期
页码:
154-156
栏目:
中医中药
出版日期:
2021-12-15

文章信息/Info

Title:
Effect of Modified Zhizi Dahuang Decoction Combined with Bifidobacterium Triple Viable Enteric-coated Capsules and Blue Light Irradiation on Neonatal Pathological Jaundice
文章编号:
1006-1959（2021）24-0154-03
作者:
陈明丽
（萍乡市湘东区妇幼保健院儿科，江西 萍乡 337000）
Author(s):
CHEN Ming-li
(Department of Pediatrics,Xiangdong Maternal and Child Health Hospital,Pingxiang 337000,Jiangxi，China)
关键词:
栀子大黄汤; 双歧杆菌; 蓝光照射; 病理性黄疸; 超敏-C反应蛋白; 胆红素
Keywords:
Zhizi Dahuang decoction; Bifidobacterium; Blue light irradiation; Pathological jaundice; Hypersensitive C-reactive protein; Bilirubin
分类号:
R722.17
DOI:
10.3969/j.issn.1006-1959.2021.24.040
文献标志码:
A
摘要:
目的 观察栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的临床效果。方法 选取2019年10月-2021年9月我院诊治的68例病理性黄疸新生儿为研究对象，采用随机数字表法分为对照组和观察组，各34例。对照组采用双歧杆菌三联活菌肠溶胶囊和蓝光照射治疗，观察组在对照组基础上给予栀子大黄汤加减治疗，比较两组临床治疗总有效率、黄疸消退时间和住院时间、血清胆红素水平和超敏-C反应蛋白、不良反应发生率。结果 观察组治疗总有效率为91.18%，高于对照组的82.35%（P＜0.05）；观察组黄疸消退时间、住院时间短于对照组（P＜0.05）；观察组胆红素、超敏-C反应蛋白水平低于对照组（P＜0.05）；两组不良反应总发生率比较，差异无统计学意义（P＞0.05）。结论 采用栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的效果确切，可缩短黄疸消退和住院时间，降低血清胆红素和炎症细胞因子水平，且不会增加临床不良反应发生几率。
Abstract:
Objective To observe the clinical effect of modified Zhizi Dahuang decoction combined with bifidobacterium triple viable enteric-coated capsules and blue light irradiation in the treatment of neonatal pathologic jaundice.Methods A total of 68 neonates with pathological jaundice treated in our hospital from October 2019 to September 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 34 cases in each group. The control group was treated with bifidobacteria triple viable enteric-coated capsules and blue light irradiation, and the observation group was treated with modified Zhizi Dahuang decoction on the basis of the control group. The total effective rate of clinical treatment, jaundice regression time and hospitalization time, serum bilirubin level, hypersensitivity-C reactive protein and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 91.18%, which was higher than 82.35% of the control group (P<0.05). The jaundice regression time and hospitalization time in the observation group were shorter than those in the control group (P<0.05). The levels of bilirubin and hypersensitivity-C reactive protein in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).Conclusion Modified Zhizi Dahuang decoction combined with bifidobacterium triple viable enteric-coated capsules and blue light irradiation is effective in the treatment of neonatal pathological jaundice, which can shorten the time of jaundice regression and hospitalization, reduce the levels of serum bilirubin and inflammatory cytokines, and will not increase the incidence of clinical adverse reactions.

参考文献/References:

[1]万勇峰,朱建宏.四种方案治疗新生儿黄疸的疗效及对相关生化指标的影响[J].湖南师范大学学报(医学版),2017,14(4):133-137.[2]陈爱萍,李志飞.茵栀黄口服液、丹参注射液联合蓝光照射治疗新生儿ABO溶血性黄疸的临床疗效分析[J].中华中医药学刊,2017,35(6):1587-1589.[3]逯军,凌瑶君.蓝光联合益生菌口服治疗早产儿黄疸临床观察[J].山东医药,2017,57(9):77-79.[4]罗嫚丽,曹文芳,刘豫军,等.布拉氏酵母菌联合茵栀黄口服液治疗新生儿黄疸临床观察[J].山东医药,2016,56(8):79-80.[5]罗菁,卢洪萍.茵栀黄口服液联合培菲康对新生儿黄疸的疗效及对T细胞亚群的影响[J].中华全科医学,2017,15(3):463-465.[6]董孝云,师淑锋,张璋.白蛋白联合蓝光照射治疗新生儿黄疸疗效及临床指标观察[J].中国卫生标准管理,2016,7(3):93-94.[7]张振琪,瞿晓青,高羽迪.茵陈丹芍汤治疗妊娠期肝内胆汁淤积症的临床疗效及其对Th1/Th2平衡的影响[J].浙江中医杂志,2017,52(9):634-635.[8]武兰,王彤彤.蓝光联合支持治疗对新生儿病理性黄疸患儿血清心肌酶、C-反应蛋白及α-谷胱甘肽-s-转移酶水平的影响[J].中国妇幼保健,2019,34(3):563-565.[9]Fawaz R,Baumann U,Ekong U,et al.Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the north American society for pediatric gastroenterology,hepatology,and nutrition and the european society for pediatric gastroenterology,hepatology,and nutrition[J].J Pediatr Gastroenterol Nutr,2017,64(1):154-168.[9]梅江华,雷宏涛.不同蓝光照射联合苯巴比妥对新生儿病理性黄疸疗效对比[J].西南国防医药,2017,27(10):1076-1078.[10]贾南,贾毅,郑玲芳,等.茵栀黄口服液与白蛋白联合方案对新生儿病理性黄疸胆红素、炎症细胞因子、免疫指标及相关因子的影响[J].海南医学院学报,2019,25(3):225-228.[11]张颖辉,孙小莉,冯国仙,等.葡萄糖-6-磷酸脱氢酶活性分析对病理性黄疸新生儿的临床意义[J].中国现代药物应用,2018,12(13):49-51. [12]Rets A,Clayton AL,Christensen RD,et al.Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia[J].Int J Lab Hematol,2019,41(Suppl 1):95-101.[13]徐睿霞,王甫琴,吴亚臻,等.茵栀黄口服液联合清蛋白治疗新生儿病理性黄疸疗效及安全性研究[J].重庆医学,2017,46(4):530-532.[14]郭小兰,白琳.经皮胆红素联合脐血胆红素检测预测新生儿病理性黄疸的价值[J].陕西医学杂志,2017,46(3):385-386.[15]林艾.茵栀黄颗粒、蓝光照射联合双歧三联活菌胶囊治疗新生儿黄疸的机制研究[J].海南医学院学报,2017,23(3):397-400.[16]张慧娟,王翠霞,董一慧,等.茵栀黄联合三联活菌治疗新生儿黄疸的临床研究[J].中国临床药理学杂志,2016,32(19):1742-1744.[17]王乾,王园园,张茜.布拉氏酵母菌散联合茵栀黄口服液早期干预新生儿黄疸效果和安全性分析[J].中华中医药学刊,2016,10(8):1997-1999.[18]马群英,黎明真,聂洪莉.双歧杆菌四联活菌片辅助蓝光照射治疗新生儿黄疸的疗效[J].海南医学院学报,2016,22(4): 370-372,376.[19]李海虹,王振武,游弋,等.茵栀黄汤联合双歧杆菌三联活菌治疗新生儿黄疸临床研究[J].中医学报,2017,4(1):142-145.

相似文献/References:

[1]吴 霞,肖盼盼,谢晓然,等.qRT-PCR法分析复发性SLE患者肠道双歧杆菌、 柔嫩梭菌数量的变化[J].医学信息,2018,31(05):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
　WU Xia,XIAO Pan-pan,XIE Xiao-ran,et al.Analysis of the Changes of Intestinal Bifidobacterium and Clostridium Tenella in Patients with Recurrent SLE by qRT-PCR[J].Medical Information,2018,31(24):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
[2]潘 捷,段达荣.双歧杆菌制剂对大鼠肿瘤模型化疗引起肠道炎症的影响[J].医学信息,2022,35(06):86.[doi:10.3969/j.issn.1006-1959.2022.06.021]
　PAN Jie,DUAN Da-rong.Effect of Bifidobacterium Preparation on Intestinal Inflammation Induced by Chemotherapy in Rat Tumor Model[J].Medical Information,2022,35(24):86.[doi:10.3969/j.issn.1006-1959.2022.06.021]

更新日期/Last Update: 1900-01-01